Tenshi Kaizen (TK) is focussed on delivering advanced finished dosage products driven by proprietary technology platforms, global infrastructure, and a robust quality system. Our strategy is aligned with the founder’s ethos of producing reliable and cost-effective pharmaceuticals with speed and agility. As of today, Tenshi Kaizen has investments in three proprietary technology platforms viz. InstaPillTM technology for rapid dissolve tabs, the world’s first thermostable probiotics platform (Under Triphase) , and proprietary technology to extract and develop highly bioavailable natural products (Under Olene Life Sciences)
Building on our strong global network, we are committed to fulfilling the demands of the world markets by anticipating the future needs and pioneering strategic new in-roads into the commercial pharmaceutical sector.